Aleve medication recalled nationwide due to insanitary distribution center conditions
Aleve 1's, 60 CT tablets are recalled nationwide because Gold Star Distribution's facility had insanitary conditions including rodent activity. Consumers should stop using the affected product and consult their healthcare provider.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with insanitary conditions and rodent activity in the distribution facility presents a risk of contamination to a medication. No illnesses or injuries have been reported, making this a theoretical risk rather than confirmed harm, which limits the score to 3 per the rubric.
Plain-English summary
Aleve 1's, 60 CT tablets distributed nationwide are being recalled due to Current Good Manufacturing Practice (CGMP) deviations at Gold Star Distribution Inc's distribution center. The facility had insanitary conditions, including evidence of rodent exposure and activity.
All lots of Aleve 1's, 60 CT that were within expiration date and distributed by Gold Star Distribution are included in this recall. The product was distributed to consumers nationwide.
Consumers who have this product should stop using it immediately. If you have questions or experience any health concerns, contact your healthcare provider or the FDA's MedWatch program.
The recalled product
- Product
- Aleve 1's, 60 CT
- Manufacturer
- GOLD STAR DISTRIBUTION INC
- Category
- Drug
- Hazard
- contamination
- insanitary-conditions
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry distributed by Gold Star Distribution.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27